Bank of America Corp vs 10X Genomics Inc — how do they compare? Bank of America Corp trades at $63.99 (market cap $447.54B), while 10X Genomics Inc trades at $58.7 (market cap $7.61B). The key difference: Bank of America Corp is far larger — about 58.8× 10X Genomics Inc's market cap, and Bank of America Corp pays a 2% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| BAC | TXG | |
|---|---|---|
Market Cap | $447.54B | $7.61B |
Volume | 55,637,172 | — |
Sector | Financials | Health |
52-Week High | $64.00 | $58.57 |
52-Week Low | $46.72 | $11.34 |
Dividend Yield | 2% | — |
Enterprise Value | — | $7.14B |
Signals from Pluang's Aura AI — not financial advice
Bank of America (BAC) trades at $64.00, up 1.31% today, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong fundamentals, including a P/E of 14.75 and net income margin of 28.21%, supported by revenue growth to $113.10 billion in 2025. Recent news highlights partnerships, hiring initiatives, and positive analyst coverage, with a consensus price target of $67.36.
Outlook remains positive with potential upside from capital returns and earnings growth, though risks include macroeconomic sensitivity and high RSI levels. Analyst consensus is strongly bullish with 64.82% buy ratings, indicating confidence in BAC's deposit franchise and operational strength amid evolving rate cycles.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.
Read more on BAC →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →